As the pharmaceutical industry evolves toward targeted therapies and increasingly potent and complex APIs, process control, precision and proper containment are more critical than ever.
This is why we’re excited to share that FPS Pharma is the Gold Sponsor at the upcoming Veridon Global event 2nd Annual EuroPotent 360 Summit a premier forum where industry leaders, innovators, and change-makers converge to shape the future of healthcare and pharmaceutical technology.
FPS Pharma mission is to ensure the utmost efficiency, safety and compliance in critical pharmaceutical manufacturing processes, especially in handling high-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs). With advanced containment isolators, innovative control systems, and next-level engineering solutions, FPS Pharma is empowering manufacturers to operate at new levels of excellence.
Why FPS Pharma stands out in containment and isolation technology
Pharmaceutical manufacturing increasingly depends on highly controlled systems for handling potent and sterile compounds.
What sets FPS Pharma high-containment isolators apart is not only their performance, but their design philosophy. These systems are engineered with the understanding that containment is not a constraint, but a catalyst. By enabling the safe handling of ultra-potent APIs, they unlock new possibilities in drug development, allowing manufacturers to explore new types of chemistry and to scale up with confidence. These custom isolators incorporate features such as closed transfer systems (RTPs, SBVs and others), automated cleaning (CIP/WIP), sterilization-in-place (SIP), real-time monitoring, and also advanced features such as robotic and voice-controlled systems. Every element is engineered to minimize contamination risks, maximize precision, optimize operational efficacy, and ensure compliance with the most stringent global standards.
For toxic applications, FPS Pharma develops negative-pressure custom isolators with turbulent airflow, designed to achieve containment levels from 10 µg/m3 to single-digit nanogram levels and below (from OEB 4 up to OEB 7).
Supporting next-generation HPAPI and ADC manufacturing
ADCs are continuously evolving and increasing their payload (cytotoxic drug) potency to increase their therapeutic efficacy. This leads to their success and to its rapid growth and to an increase in containment complexity. To meet this challenge, FPS Pharma has pioneered containment systems like OEB 7 isolators, representing the new frontier in ultra-potent API containment, which guarantee single-digit nanogram containment down to 1 ng/m3. Isolators).
FPS Pharma’s custom containment solutions can seamlessly integrate all the process phases and technologies, such as sampling and dispensing, reactor charging, filtration and drying, ANFD discharge, milling, micronization, filling, packaging and quality control, and customer’s equipment. This application-driven approach helps customers simplify process steps, minimize operator exposure risks, optimize workflow and ensure utmost product quality.
Innovation that improves both compliance and operational efficiency
In addition to FPS Pharma isolator technologies and micronization systems, FPS Pharma offers advanced glove leak testing devices such as GloveXpert, its patented wireless glove leak tester for isolators and RABS. It performs reliable and repeatable integrity testing on both gloves and glove ports using the positive pressure decay method, in full compliance with UNI EN ISO 14644-7.
Designed for speed, safety and ease of use, GloveXpert can complete a test in 4 to 9 minutes, perform up to 120 test cycles on a single charge, detect holes as small as 100 microns, and supports features such as RFID, Wi-Fi connectivity, and many other features which make glove testing easy, ultra-accurate and fast. It reflects FPS Pharma’s broader commitment to combining smart engineering with practical, inspection-ready solutions for pharmaceutical operations.
Looking Ahead: FPS Pharma at Veridon Global
As Veridon Global brings together leaders from across healthcare, life sciences, and technology, FPS Pharma’s role as Gold Sponsor underscores its strategic vision: to help the industry innovate boldly while operating within the highest standards of safety and compliance. From high-containment isolators to next-generation API manufacturing solutions, FPS Pharma continues to push boundaries and redefine what’s possible in pharmaceutical production.
We look forward to meaningful conversations at 2nd Annual EuroPotent 360 Summit — connecting, learning, and co-creating safer, smarter pharmaceutical futures. Stay tuned for more insights and highlights from the event!
